1. Home
  2. ARDX vs PGY Comparison

ARDX vs PGY Comparison

Compare ARDX & PGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$7.99

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Pagaya Technologies Ltd.

PGY

Pagaya Technologies Ltd.

HOLD

Current Price

$21.85

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARDX
PGY
Founded
2007
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.8B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
ARDX
PGY
Price
$7.99
$21.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
7
Target Price
$12.95
$39.43
AVG Volume (30 Days)
6.3M
3.0M
Earning Date
02-19-2026
02-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$398,234,000.00
$1,245,946,000.00
Revenue This Year
$22.65
$28.75
Revenue Next Year
$31.33
$17.23
P/E Ratio
N/A
N/A
Revenue Growth
58.12
28.33
52 Week Low
$3.21
$8.50
52 Week High
$8.17
$44.99

Technical Indicators

Market Signals
Indicator
ARDX
PGY
Relative Strength Index (RSI) 66.23 43.84
Support Level $6.73 $20.62
Resistance Level $7.25 $26.80
Average True Range (ATR) 0.57 1.41
MACD 0.14 -0.20
Stochastic Oscillator 89.03 20.23

Price Performance

Historical Comparison
ARDX
PGY

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About PGY Pagaya Technologies Ltd.

Pagaya Technologies Ltd is a financial technology company working to reshape the lending marketplace by using machine learning, data analytics, and sophisticated AI-driven credit and analysis technology. It was built to provide a comprehensive solution to enable the credit industry to deliver customers a positive experience while simultaneously enhancing the broader credit ecosystem. Its proprietary API seamlessly integrates into its next-gen infrastructure network of partners to deliver a premium customer user experience and greater access to credit. The company generates majority of its revenue from United States.

Share on Social Networks: